Parkinson S Stem Cell Treatment Clinical Trials

And medical therapy for parkinson s is so advanced that transplantation right now probably isn t going to be any better than what we can already do.

Parkinson s stem cell treatment clinical trials.

Carlsbad ca international stem cell corporation otcqb. Parkinson s uk has invested more than 3 million in cutting edge stem cell research to help develop new and better treatments for parkinson s faster. Patient enrollment and dosing is now complete for international stem cell corporation s isco phase 1 trial testing its isc hpnsc neural stem cells a cellular therapy that offers a new approach for treating parkinson s disease. How can people with parkinson s disease pd assess the safety of clinical trials for stem cell therapies.

This clinical trial under way at the royal melbourne hospital in australia is designed to demonstrate the safety of isc hpnsc as a treatment for parkinson s disease. We are excited to announce the completion of enrollment of the world s first approved human pluripotent stem cell based clinical trial for the treatment. Yesterday a team of neurologists neurosurgeons and stem cell biologists from across multiple institutions reported results of a stem cell trial involving one person with parkinson s in the new england journal of medicine the trial also was covered by top science reporter sharon begley of stat. But that doesn t mean we shouldn t be forging ahead using stem cells to discover more about the disease in order to find new drugs as well as refine our ideas about transplantation.

With all clinical trials ensuring that the treatment is safe and effective is paramount and along with the international research community we will be watching the progress of the trial very. Four groups dedicated to using stem cell therapies to treat parkinson s disease have formed an international consortium known as g force pd. In the first of its kind study the patient s own stem cells were turned into dopamine. The future of stem cell therapy for parkinson s.

After years of study stem cell treatments which involve transplanting cells to replace the brain cells lost in pd are being tested in clinicaltrials around the world. Isco a california based clinical stage biotechnology company developing stem cell based therapies and biomedical products announced today the positive six months interim results of the first cohort of parkinson s disease pd patients receiving 30 million isc hpnsc cells in the ongoing clinical study.